Nektar Therapeutics Names John Northcott Chief Commercial Officer

John Northcott has joined Nektar Therapeutics (NASDAQ: [[ticker:NKTR]]) in the newly created role of senior vice president and chief commercial officer. Northcott was most recently the chief commercial officer of AbbVie (NYSE: [[ticker:ABBV]]) subsidiary Pharmacyclics. His experience also includes positions at Roche’s Genentech unit, Lexicon Pharmaceuticals (NASDAQ: [[ticker:LXRX]]), Merck (NYSE: [[ticker:MRK]]), and Pfizer (NYSE: [[ticker:PFE]]). San Francisco-based Nektar is developing drugs for cancer, autoimmune diseases, and chronic pain.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan